AcuCort (ACUC.SL) Stock Price

AcuCort Price

CLOSED
0.49
​
Market closed

AcuCort stock price

Access this data via the Eulerpool API

AcuCort business model & stock analysis

AcuCort AB engages in the development, market, and sale of Dexa oral dissolvable films. The company is headquartered in Lund, Skane and currently employs 4 full-time employees. The company went IPO on 2017-04-24. The firm develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.

Frequently asked questions about AcuCort

Converted at the current exchange rate, the AcuCort share trades at 0.04 EUR (0.49 SEK).

The revenue cannot currently be calculated for AcuCort.

The profit cannot currently be calculated for AcuCort.

The P/E ratio cannot be calculated for AcuCort at the moment.

The P/S cannot be calculated for AcuCort currently.

The Eulerpool Quality Score for AcuCort is 3/10.

The ISIN of AcuCort is SE0009695927. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of AcuCort is ACUC.SL. The ticker symbol is used to trade AcuCort shares on the stock exchange.

Fair ValueTerminal
0.40 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
168,750.00 SEK
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website acucort.se
Country
Sweden
Currency
SEK
Initial public offering
Apr 24, 2017
ISIN
SE0009695927
Cusip
W0501Z101
Market capitalization
110.12 M SEKMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.70
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-42.59 %
Gross Margin
1,143.26 %
EBIT Margin
-2,575.56 %
Net Margin
-2,577.48 %
EPS (Earnings Per Share)
-0.12 SEK
Net Debt / EBIT
0.16
Debt/Equity
0.00
Last updated Oct 5, 2026, 5:16 PM

AcuCort Peer Group

All fundamentals and in-depth analysis of AcuCort

Our stock analysis for AcuCort stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AcuCort. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.